martes, 2 de septiembre de 2014

National Guideline Clearinghouse | Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement.

full-text ►

National Guideline Clearinghouse | Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement.



U.S. Preventive Services Task Force

National Guideline Clearinghouse (NGC)

Guideline Title
Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement.
Bibliographic Source(s)
U.S. Preventive Services Task Force. Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014 Jun 3;160(11):791-7. [24 references] PubMed External Web Site Policy
Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: U.S. Preventive Services Task Force. Screening for dementia: recommendations and rationale. Ann Intern Med 2003;138(11):925-6.
This guideline meets NGC's 2013 (revised) inclusion criteria.

 2014 Jun 3;160(11):791-7. doi: 10.7326/M14-0496.

Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement.

Abstract

DESCRIPTION:

Update of the 2003 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for dementia.

METHODS:

The USPSTF reviewed the evidence on the benefits, harms, and sensitivity and specificity of screening instruments for cognitive impairment in older adults and the benefits and harms of commonly used treatment and management options for older adults with mild cognitive impairment or early dementia and their caregivers.

POPULATION:

This recommendation applies to universal screening with formal screening instruments in community-dwelling adults in the general primary care population who are older than 65 years and have no signs or symptoms of cognitive impairment.

RECOMMENDATION:

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for cognitive impairment. (I statement).

PMID:
 
24663815
 
[PubMed - indexed for MEDLINE]

No hay comentarios:

Publicar un comentario